Although the contribution of survivin to the modulation of invasiveness has been well demonstrated in cervical cancer cells [24], whether survivin can serve as a therapeutic target for the purpose of inducing apoptosis remains unknown. Here, BIRC5 is linked to cervical carcinoma.